Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 16, 2016 - Issue 7
Submit an article Journal homepage
964
Views
111
CrossRef citations to date
0
Altmetric
Review

Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine

Robert ZivadinovBuffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA;MR Imaging Clinical Translational Research Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USACorrespondence[email protected]
,
Dejan JakimovskiBuffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
,
Sirin GandhiBuffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
,
Rahil AhmedBuffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
,
Michael G. DwyerBuffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
,
Dana HorakovaDepartment of Neurology and Center of Clinical Neuroscience, Charles University in Prague, First Faculty of Medicine and General University Hospital, Prague, Czech Republic
,
Bianca Weinstock-GuttmanJacobs Multiple Sclerosis Center, Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
,
Ralph R. H. BenedictJacobs Multiple Sclerosis Center, Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
,
Manuela VaneckovaDepartment of Radiology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic
,
Michael BarnettSydney Neuroimaging Analysis Centre; Brain & Mind Centre, University of Sydney, Sydney, Australia
&
Niels BergslandBuffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA;IRCCS ‘S.Maria Nascente’, Don Gnocchi Foundation, Milan, Italy
 show all
Pages 777-793 | Received 18 Feb 2016, Accepted 19 Apr 2016, Published online: 13 May 2016

Citations (111)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Francesco Corallo, Carmela Rifici, Lilla Bonanno, Marcella Di Cara, Viviana Lo Buono, Giuseppe Venuti, Silvia Marino, Rosella Ciurleo, Viviana Torre, Giangaetano D’Aleo, Placido Bramanti & Edoardo Sessa. (2022) The role of teriflunomide in Multiple Sclerosis patient: an observational study. Psychology, Health & Medicine 27:10, pages 2204-2211.
Read now
Koung Mi Kang, Chul-Ho Sohn, Min Soo Byun, Jun Ho Lee, Dahyun Yi, Younghwa Lee, Jun-Young Lee, Yu Kyeong Kim, Bo Kyung Sohn, Roh-Eul Yoo, Tae Jin Yun, Seung Hong Choi, Ji-hoon Kim & Dong Young Lee. (2020) Prediction of Amyloid Positivity in Mild Cognitive Impairment Using Fully Automated Brain Segmentation Software. Neuropsychiatric Disease and Treatment 16, pages 1745-1754.
Read now
Eleonora Tavazzi, Robert Zivadinov, Michael G. Dwyer, Dejan Jakimovski, Tarun Singhal, Bianca Weinstock-Guttman & Niels Bergsland. (2020) MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis. Expert Review of Neurotherapeutics 20:8, pages 821-834.
Read now

Articles from other publishers (108)

Robert Zivadinov, Jinglan Pei, David Clayton, Donna E Goldman, Ryan C Winger, Mark S Cabatingan, Michael G Dwyer & Niels Bergsland. (2023) Evolution of atrophied T2 lesion volume in primary-progressive multiple sclerosis: results from the phase 3 ORATORIO study. Journal of Neurology, Neurosurgery & Psychiatry, pages jnnp-2023-332573.
Crossref
Pablo Naval-Baudin, Pablo Arroyo-Pereiro & Carles Majós. (2023) The pressing need for imaging biomarkers of disability progression in multiple sclerosis. European Radiology.
Crossref
Glenn R. Wylie, Helen M. Genova, Bing Yao, Nancy Chiaravalloti, Cristina A. F. Román, Brian M. Sandroff & John DeLuca. (2023) Evaluating the effects of brain injury, disease and tasks on cognitive fatigue. Scientific Reports 13:1.
Crossref
Ann‐Kathrin Nold, Matthias Wittayer, Claudia E. Weber, Michael Platten, Achim Gass & Philipp Eisele. (2023) Short‐term brain atrophy evolution after initiation of immunotherapy in a real‐world multiple sclerosis cohort. Journal of Neuroimaging 33:6, pages 904-908.
Crossref
Dejan Jakimovski, Stefan Bittner, Robert Zivadinov, Sarah A Morrow, Ralph HB Benedict, Frauke Zipp & Bianca Weinstock-Guttman. (2023) Multiple sclerosis. The Lancet.
Crossref
Daniel Ontaneda, Tanuja Chitnis, Kottil Rammohan & Ahmed Z. Obeidat. (2023) Identification and management of subclinical disease activity in early multiple sclerosis: a review. Journal of Neurology.
Crossref
Aleksandra Pogoda-Wesołowska, Angela Dziedzic, Karina Maciak, Adam Stȩpień, Marta Dziaduch & Joanna Saluk. (2023) Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review. Frontiers in Molecular Neuroscience 16.
Crossref
Magdalena Chylińska, Jakub Komendziński, Adam Wyszomirski & Bartosz Karaszewski. (2023) Brain Atrophy as an Outcome of Disease-Modifying Therapy for Remitting-Relapsing Multiple Sclerosis. Multiple Sclerosis International 2023, pages 1-11.
Crossref
Maureen van Dam, Brigit A. de Jong, Eline A. J. Willemse, Ilse M. Nauta, Marijn Huiskamp, Martin Klein, Bastiaan Moraal, Sanne de Geus-Driessen, Jeroen J. G. Geurts, Bernard M. J. Uitdehaag, Charlotte E. Teunissen & Hanneke E. Hulst. (2023) A multimodal marker for cognitive functioning in multiple sclerosis: the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort. Journal of Neurology 270:8, pages 3851-3861.
Crossref
Dejan Jakimovski, Ferhan Qureshi, Murali Ramanathan, Victor Gehman, Anisha Keshavan, Kelly Leyden, Michael G Dwyer, Niels Bergsland, Bianca Weinstock-Guttman & Robert Zivadinov. (2023) Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging study. Brain Communications 5:3.
Crossref
Robert Zivadinov & Michael G. Dwyer. (2023) Spinning Gold out of Straw: Using Modern AI Methods to Create Sequences for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection When Only Conventional Imaging Is Available. Radiology 307:2.
Crossref
Stephen L. HauserAmit Bar-OrMartin S. WeberHeidemarie KletzlAndreas GüntherMarianna ManfriniFabian ModelFrancois MercierClaire PetryQing WingHarold KoendgenTerence SmithLudwig Kappos. (2023) Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation 10:2.
Crossref
Smaranda Maier, Laura Barcutean, Sebastian Andone, Doina Manu, Emanuela Sarmasan, Zoltan Bajko & Rodica Balasa. (2023) Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis. International Journal of Molecular Sciences 24:5, pages 4375.
Crossref
Penny Pennington, Bianca Weinstock-Guttman, Channa Kolb, Dejan Jakimovski, Katherine Sacca, Ralph H. B. Benedict, Svetlana Eckert, Marc Stecker, Alexis Lizarraga, Michael G. Dwyer, Carol B. Schumacher, Niels Bergsland, Patricia Picco, Evanthia Bernitsas, Rana Zabad, Gabriel Pardo, Donald Negroski, Martin Belkin, David Hojnacki & Robert Zivadinov. (2022) Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives. Journal of Neurology 270:2, pages 1095-1119.
Crossref
Angela Genchi, Elena Brambilla, Francesca Sangalli, Marta Radaelli, Marco Bacigaluppi, Roberto Furlan, Annapaola Andolfo, Denise Drago, Cinzia Magagnotti, Giulia Maria Scotti, Raffaella Greco, Paolo Vezzulli, Linda Ottoboni, Marco Bonopane, Daniela Capilupo, Francesca Ruffini, Daniela Belotti, Benedetta Cabiati, Stefania Cesana, Giada Matera, Letizia Leocani, Vittorio Martinelli, Lucia Moiola, Luca Vago, Paola Panina-Bordignon, Andrea Falini, Fabio Ciceri, Anna Uglietti, Maria Pia Sormani, Giancarlo Comi, Mario Alberto Battaglia, Maria A. Rocca, Loredana Storelli, Elisabetta Pagani, Giuseppe Gaipa & Gianvito Martino. (2023) Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study. Nature Medicine 29:1, pages 75-85.
Crossref
Samuel Klistorner, Michael H Barnett & Alexander Klistorner. (2022) Mechanisms of central brain atrophy in multiple sclerosis. Multiple Sclerosis Journal 28:13, pages 2038-2045.
Crossref
Eman M. Khedr, Tarek Desoky, Ayman Gamea, Mohammed Y. Ezzeldin & Ahmed F. Zaki. (2022) Thalamic atrophy, duration of illness, and years of education are the best predictors of cognitive impairment in multiple sclerosis. Clinical and Experimental Neuroimmunology 13:4, pages 216-225.
Crossref
Qinming Zhou, Tianxiao Zhang, Huanyu Meng, Dingding Shen, Yao Li, Lu He, Yining Gao, Yizongheng Zhang, Xinyun Huang, Hongping Meng, Biao Li, Min Zhang & Sheng Chen. (2022) Characteristics of cerebral blood flow in an Eastern sample of multiple sclerosis patients: A potential quantitative imaging marker associated with disease severity. Frontiers in Immunology 13.
Crossref
Robert Zivadinov, Niels Bergsland, Dejan Jakimovski, Bianca Weinstock-Guttman, Ralph H B Benedict, Jon Riolo, Diego Silva & Michael G Dwyer. (2022) Thalamic atrophy measured by artificial intelligence in a multicentre clinical routine real-world study is associated with disability progression. Journal of Neurology, Neurosurgery & Psychiatry 93:10, pages 1128-1136.
Crossref
Brian M. Sandroff, Robert W. Motl, Cristina A. F. Román, Glenn R. Wylie, John DeLuca, Gary R. Cutter, Ralph H. B. Benedict, Michael G. Dwyer & Robert Zivadinov. (2022) Thalamic atrophy moderates associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with multiple sclerosis. Journal of Neurology 269:10, pages 5531-5540.
Crossref
Morten Riemenschneider, Lars G Hvid, Steffen Ringgaard, Mikkel Karl Emil Nygaard, Simon Fristed Eskildsen, Tobias Gaemelke, Melinda Magyari, Henrik Boye Jensen, Helle Hvilsted Nielsen, Matthias Kant, Masoud Falah, Thor Petersen, Egon Stenager & Ulrik Dalgas. (2022) Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis: The Early Multiple Sclerosis Exercise Study (EMSES). Multiple Sclerosis Journal 28:10, pages 1620-1629.
Crossref
Dejan Jakimovski, Robert Zivadinov, Niels Bergsland, Jiwon Oh, Melissa Martin, Russell T. Shinohara, Rohit Bakshi, Peter A. Calabresi, Nico Papinutto, Daniel Pelletier & Michael G. Dwyer. (2022) Multisite MRI reproducibility of lateral ventricular volume using the NAIMS cooperative pilot dataset. Journal of Neuroimaging 32:5, pages 910-919.
Crossref
Brian M Sandroff, Robert W Motl, V Wee Yong, Gary R Cutter & Gavin Giovannoni. (2022) Exercise training in multiple sclerosis. The Lancet Neurology 21:4, pages 313.
Crossref
Jie Sun, Yingying Xie, Qiuhui Wang, Junlin Shen, Wen Qin, Ningnannan Zhang & Chunshui Yu. (2021) Genes associated with grey matter volume reduction in multiple sclerosis. Journal of Neurology 269:4, pages 2004-2015.
Crossref
Maria Chiara Buscarinu, Roberta Reniè, Emanuele Morena, Carmela Romano, Gianmarco Bellucci, Antonio Marrone, Rachele Bigi, Marco Salvetti & Giovanni Ristori. (2022) Late-Onset MS: Disease Course and Safety-Efficacy of DMTS. Frontiers in Neurology 13.
Crossref
Kouichi Nishizawa, Juichi Fujimori & Ichiro Nakashima. (2022) Two-dimensional measurements with cut-off values are useful for assessing brain volume, physical disability, and processing speed in multiple sclerosis. Multiple Sclerosis and Related Disorders 59, pages 103543.
Crossref
Satori Ajitomi, Juichi Fujimori & Ichiro Nakashima. (2022) Usefulness of two-dimensional measurements for the evaluation of brain volume and disability in multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical 8:1, pages 205521732110707.
Crossref
Zhuang Song, Anithapriya Krishnan, Laura Gaetano, Nicholas J. Tustison, David Clayton, Alex de Crespigny, Thomas Bengtsson, Xiaoming Jia & Richard A.D. Carano. (2022) Deformation-based morphometry identifies deep brain structures protected by ocrelizumab. NeuroImage: Clinical 34, pages 102959.
Crossref
Scott D. Newsome, Thomas F. Scott, Douglas L. Arnold, Arman Altincatal & Maria L. Naylor. (2022) Early treatment responses to peginterferon beta-1a are associated with longer-term clinical outcomes in patients with relapsing-remitting multiple sclerosis: Subgroup analyses of ADVANCE and ATTAIN. Multiple Sclerosis and Related Disorders 57, pages 103367.
Crossref
Dejan Jakimovski, Samreen Awan, Svetlana P. Eckert, Osman Farooq & Bianca Weinstock-Guttman. (2021) Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment. CNS Drugs 36:1, pages 45-59.
Crossref
Antonio Carlos da Silva Senra Filho, Fabrício Henrique Simozo & Luiz Otávio Murta Junior. (2021) Brain volume refinement (BVeR): automatic correction tool as an alternative to manual intervention on brain segmentation. Research on Biomedical Engineering 37:4, pages 631-640.
Crossref
Jarmila Szilasiová, Pavol Mikula, Jaroslav Rosenberger, Miriam Fedičová, Zuzana Gdovinová, Peter Urban & Lýdia Frigová. (2021) Plasma neurofilament light chain levels are predictors of disease activity in multiple sclerosis as measured by four-domain NEDA status, including brain volume loss. Multiple Sclerosis Journal 27:13, pages 2023-2030.
Crossref
Vicki E Maltby, Rodney A Lea, Mastura Monif, Marzena J Fabis-Pedrini, Katherine Buzzard, Tomas Kalincik, Allan G Kermode, Bruce Taylor, Suzanne Hodgkinson, Pamela McCombe, Helmut Butzkueven, Michael Barnett & Jeannette Lechner-Scott. (2021) Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study). JMIR Research Protocols 10:10, pages e24969.
Crossref
Nik Krajnc, Gabriel Bsteh & Thomas Berger. (2021) Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review. Frontiers in Neurology 12.
Crossref
Dejan Jakimovski, Michael G Dwyer, Niels Bergsland, Bianca Weinstock-Guttman & Robert Zivadinov. (2021) Disease biomarkers in multiple sclerosis: current serum neurofilament light chain perspectives. Neurodegenerative Disease Management 11:4, pages 329-340.
Crossref
Dejan Jakimovski, Robert Zivadinov, Caila B. Vaughn, Osman Ozel & Bianca Weinstock-Guttman. (2021) Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosis. Journal of the Neurological Sciences 427, pages 117552.
Crossref
Giuseppe Fenu, Lorena Lorefice, Elisa Carta, Mauro Arru, Alice Carta, Marzia Fronza, Giancarlo Coghe, Jessica Frau, Franco Contu, Maria Antonietta Barracciu & Eleonora Cocco. (2021) Brain Volume and Perception of Cognitive Impairment in People With Multiple Sclerosis and Their Caregivers. Frontiers in Neurology 12.
Crossref
Jessica F. Baird & Robert W. Motl. (2021) Cognitive Function and Whole-Brain MRI Metrics Are Not Associated with Mobility in Older Adults with Multiple Sclerosis. International Journal of Environmental Research and Public Health 18:8, pages 4232.
Crossref
Evanthia Bernitsas, Hannah Kopinsky, Samuel Lichtman‐Mikol, Sarah Razmjou, Carla Santiago‐Martinez, Kalyan Yarraguntla & Fen Bao. (2020) Multimodal MRI Response to Fingolimod in Multiple Sclerosis: A Nonrandomized, Single Arm, Observational Study. Journal of Neuroimaging 31:2, pages 379-387.
Crossref
Tomas Uher, Niels Bergsland, Jan Krasensky, Michael G. Dwyer, Michaela Andelova, Lukas Sobisek, Eva Kubala Havrdova, Dana Horakova, Robert Zivadinov & Manuela Vaneckova. (2020) Interpretation of Brain Volume Increase in Multiple Sclerosis. Journal of Neuroimaging 31:2, pages 401-407.
Crossref
Nicola De Stefano, Antonio Giorgio, Giordano Gentile, Maria Laura Stromillo, Rosa Cortese, Claudio Gasperini, Andrea Visconti, Maria Pia Sormani & Marco Battaglini. (2021) Dynamics of pseudo‐atrophy in RRMS reveals predominant gray matter compartmentalization. Annals of Clinical and Translational Neurology 8:3, pages 623-630.
Crossref
Morten Riemenschneider, Lars G Hvid, Steffen Ringgaard, Mikkel K E Nygaard, Simon F Eskildsen, Thor Petersen, Egon Stenager & Ulrik Dalgas. (2021) Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES). BMJ Open 11:1, pages e043699.
Crossref
Tom A. Fuchs, Michael G. Dwyer, Dejan Jakimovski, Niels Bergsland, Deepa P. Ramasamy, Bianca Weinstock-Guttman, Ralph HB Benedict & Robert Zivadinov. (2021) Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI. NeuroImage: Clinical 31, pages 102705.
Crossref
Michael Dwyer, Cassondra Lyman, Hannah Ferrari, Niels Bergsland, Tom A. Fuchs, Dejan Jakimovski, Ferdinand Schweser, Bianca Weinstock-Guttmann, Ralph H.B. Benedict, Jon Riolo, Diego Silva & Robert Zivadinov. (2021) DeepGRAI (Deep Gray Rating via Artificial Intelligence): Fast, feasible, and clinically relevant thalamic atrophy measurement on clinical quality T2-FLAIR MRI in multiple sclerosis. NeuroImage: Clinical 30, pages 102652.
Crossref
Dejan Jakimovski, Robert Zivadinov, Niels Bergsland, Deepa P. Ramasamy, Jesper Hagemeier, Antonia Valentina Genovese, David Hojnacki, Bianca Weinstock-Guttman & Michael G. Dwyer. (2021) Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes. NeuroImage: Clinical 29, pages 102554.
Crossref
Sorama Aoki, Juichi Fujimori, Ryoko Mikami, Kenji Hoshi, Junko Kawakami, Kenichi Sato & Ichiro Nakashima. (2021) Assisting the diagnosis of multiple sclerosis using a set of regional brain volumes: A classification model for patients and healthy controls. Informatics in Medicine Unlocked 26, pages 100766.
Crossref
Marcus Sucksdorff, Markus Matilainen, Jouni Tuisku, Eero Polvinen, Anna Vuorimaa, Johanna Rokka, Marjo Nylund, Eero Rissanen & Laura Airas. (2020) Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis. Brain 143:11, pages 3318-3330.
Crossref
Dejan Jakimovski, Robert Zivadinov, Bianca Weinstock-Guttman, Niels Bergsland, Michael G. Dwyer & Marcella Maria Lagana. (2020) Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy. Fluids and Barriers of the CNS 17:1.
Crossref
Jason M. Millward, Paula Ramos Delgado, Alina Smorodchenko, Laura Boehmert, Joao Periquito, Henning M. Reimann, Christian Prinz, Antje Els, Michael Scheel, Judith Bellmann-Strobl, Helmar Waiczies, Jens Wuerfel, Carmen Infante-Duarte, Andreas Pohlmann, Frauke Zipp, Friedemann Paul, Thoralf Niendorf & Sonia Waiczies. (2020) Transient enlargement of brain ventricles during relapsing-remitting multiple sclerosis and experimental autoimmune encephalomyelitis. JCI Insight 5:21.
Crossref
Dejan Jakimovski, Robert Zivadinov, Murali Ramanthan, Jesper Hagemeier, Bianca Weinstock-Guttman, Davorka Tomic, Harald Kropshofer, Tom A Fuchs, Christian Barro, David Leppert, Özgür Yaldizli, Jens Kuhle & Ralph HB Benedict. (2019) Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study. Multiple Sclerosis Journal 26:13, pages 1670-1681.
Crossref
Dejan Jakimovski, Dora Dujmic, Jesper Hagemeier, Deepa P. Ramasamy, Niels Bergsland, Michael G. Dwyer, Svetlana Eckert, Channa Kolb, Alexis Lizarraga, David Hojnacki, Bianca Weinstock-Guttman & Robert Zivadinov. (2020) Late onset multiple sclerosis is associated with more severe ventricle expansion. Multiple Sclerosis and Related Disorders 46, pages 102588.
Crossref
Dana Horakova, Tomas Uher, Jan Krasensky, Zdeněk Seidl, Annemie Ribbens, Wim Van Hecke, Thibo Billiet, Harold Koendgen, Ulrich Freudensprung, Robert Hyde & Manuela Vaneckova. (2020) Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study. Multiple Sclerosis and Related Disorders 46, pages 102543.
Crossref
Dejan Jakimovski, Robert Zivadinov, Michael G. Dwyer, Niels Bergsland, Deepa P. Ramasamy, Richard W. Browne, Bianca Weinstock-Guttman & Murali Ramanathan. (2020) High density lipoprotein cholesterol and apolipoprotein A-I are associated with greater cerebral perfusion in multiple sclerosis. Journal of the Neurological Sciences 418, pages 117120.
Crossref
Juichi Fujimori, Kengo Uryu, Kazuo Fujihara, Mike P. Wattjes, Chihiro Suzuki & Ichiro Nakashima. (2020) Measurements of the corpus callosum index and fractional anisotropy of the corpus callosum and their cutoff values are useful to assess global brain volume loss in multiple sclerosis. Multiple Sclerosis and Related Disorders 45, pages 102388.
Crossref
Dejan Jakimovski, Niels Bergsland, Michael G. Dwyer, Deepa P. Ramasamy, Murali Ramanathan, Bianca Weinstock-Guttman & Robert Zivadinov. (2020) Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis. Diagnostics 10:9, pages 685.
Crossref
Robert Zivadinov & Niels Bergsland. (2020) Cervical Spinal Cord Lesions and Atrophy versus Brain Measures in Explaining Physical Disability in Multiple Sclerosis. Radiology 296:3, pages 616-618.
Crossref
Lin Zhao, Jill Abrigo, Qianyun Chen, Cheryl Au, Angel Ng, Ping Fan, Vincent Mok, Wei Qiu, Allan G. Kermode & Alexander Y. Lau. (2020) Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands. Scientific Reports 10:1.
Crossref
Katariina Hänninen, Matias Viitala, Teemu Paavilainen, Jari O. Karhu, Juha Rinne, Juha Koikkalainen, Jyrki Lötjönen & Merja Soilu-Hänninen. (2020) Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis. Frontiers in Neurology 11.
Crossref
Eleonora TavazziDejan Jakimovski, Jens KuhleJesper HagemeierOsman OzelMurali RamanathanChristian BarroNiels BergslandDavorka TomicHarald KropshoferDavid LeppertZuzanna MichalakNorah LincoffMichael G. DwyerRalph H.B. BenedictBianca Weinstock-GuttmanRobert Zivadinov. (2020) Serum neurofilament light chain and optical coherence tomography measures in MS. Neurology Neuroimmunology & Neuroinflammation 7:4.
Crossref
Tomas Uher, Sabine SchaedelinBarbora SrpovaChristian BarroNiels BergslandMichael DwyerMichaela TyblovaKarolina VodehnalovaPascal Benkert, Johanna OechteringDavid LeppertYvonne NaegelinJan KrasenskyManuela VaneckovaEva Kubala HavrdovaLudwig KapposRobert ZivadinovDana HorakovaJens KuhleTomas Kalincik. (2020) Monitoring of radiologic disease activity by serum neurofilaments in MS. Neurology Neuroimmunology & Neuroinflammation 7:4.
Crossref
Dejan Jakimovski, Niels Bergsland, Michael G. Dwyer, Jesper Hagemeier, Deepa P. Ramasamy, Kinga Szigeti, Thomas Guttuso, David Lichter, David Hojnacki, Bianca Weinstock-Guttman, Ralph H.B. Benedict & Robert Zivadinov. (2020) Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson’s disease, mild cognitive impairment, Alzheimer’s disease, and elderly healthy controls. Neurobiology of Aging 90, pages 84-92.
Crossref
Dejan Jakimovski, Robert Zivadinov, Niels Bergsland, Deepa P. Ramasamy, Jesper Hagemeier, Bianca Weinstock‐Guttman, Channa Kolb, David Hojnacki & Michael G. Dwyer. (2020) Sex‐Specific Differences in Life Span Brain Volumes in Multiple Sclerosis. Journal of Neuroimaging 30:3, pages 342-350.
Crossref
Eleonora Tavazzi, Niels Bergsland, Jens Kuhle, Dejan Jakimovski, Murali Ramanathan, Aleksandra M. Maceski, Davorka Tomic, Jesper Hagemeier, Harald Kropshofer, David Leppert, Michael G. Dwyer, Bianca Weinstock-Guttman, Ralph H. B. Benedict & Robert Zivadinov. (2019) A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis. Journal of Neurology 267:3, pages 802-811.
Crossref
N. Ziliotto, R. Zivadinov, M. Baroni, G. Marchetti, D. Jakimovski, N. Bergsland, D. P. Ramasamy, B. Weinstock‐Guttman, S. Straudi, F. Manfredini, M. Ramanathan & F. Bernardi. (2019) Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis. European Journal of Neurology 27:2, pages 235-243.
Crossref
Cecilie Jacobsen, Robert Zivadinov, Kjell-Morten Myhr, Turi O Dalaker, Ingvild Dalen, Niels Bergsland & Elisabeth Farbu. (2020) Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study. Multiple Sclerosis Journal - Experimental, Translational and Clinical 6:1, pages 205521732090248.
Crossref
Dejan Jakimovski, Deepa P. Ramasamy & Robert Zivadinov. 2020. Clinical Neuroimmunology. Clinical Neuroimmunology 109 136 .
Jeroen Van Schependom, Kaat Guldolf, Marie Béatrice D’hooghe, Guy Nagels & Miguel D’haeseleer. (2019) Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in. Translational Neurodegeneration 8:1.
Crossref
Antonia Valentina Genovese, Jesper Hagemeier, Niels Bergsland, Dejan Jakimovski, Michael G. Dwyer, Deepa P. Ramasamy, Alexis A. Lizarraga, David Hojnacki, Channa Kolb, Bianca Weinstock-Guttman & Robert Zivadinov. (2019) Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis. Radiology 293:2, pages 424-433.
Crossref
Fulvio Zaccagna, Tomasz Matys & Tarik F. Massoud. (2019) Optic Chiasm Morphometric Changes in Multiple Sclerosis: Feasibility of a Simplified Brain Magnetic Resonance Imaging Measure of White Matter Atrophy. Clinical Anatomy 32:8, pages 1072-1081.
Crossref
Dejan Jakimovski, Jens Kuhle, Murali Ramanathan, Christian Barro, Davorka Tomic, Jesper Hagemeier, Harald Kropshofer, Niels Bergsland, David Leppert, Michael G. Dwyer, Zuzanna Michalak, Ralph H. B. Benedict, Bianca Weinstock‐Guttman & Robert Zivadinov. (2019) Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study. Annals of Clinical and Translational Neurology 6:9, pages 1757-1770.
Crossref
Robert Zivadinov & Michael G. Dwyer. (2019) Network Dynamics and Cognitive Impairment in Multiple Sclerosis: Functional MRI–based Decoupling of Complex Relationships. Radiology 292:2, pages 458-459.
Crossref
Hiroki Masuda, Masahiro Mori, Shigeki Hirano, Kazuho Kojima, Akiyuki Uzawa, Tomohiko Uchida, Ryohei Ohtani & Satoshi Kuwabara. (2019) Relapse numbers and earlier intervention by disease modifying drugs are related with progression of less brain atrophy in patients with multiple sclerosis. Journal of the Neurological Sciences 403, pages 78-84.
Crossref
Emanuele Ghione, Niels Bergsland, Michael G. Dwyer, Jesper Hagemeier, Dejan Jakimovski, Ivo Paunkoski, Deepa P. Ramasamy, Ellen Carl, David Hojnacki, Channa Kolb, Bianca Weinstock‐Guttman & Robert Zivadinov. (2019) Aging and Brain Atrophy in Multiple Sclerosis. Journal of Neuroimaging 29:4, pages 527-535.
Crossref
Daniel Kor, Christoph Birkl, Stefan Ropele, Jonathan Doucette, Tianyou Xu, Vanessa Wiggermann, Enedino Hernández‐Torres, Simon Hametner & Alexander Rauscher. (2019) The role of iron and myelin in orientation dependent R 2 * of white matter . NMR in Biomedicine 32:7.
Crossref
Caila B. Vaughn, Dejan Jakimovski, Katelyn S. Kavak, Murali Ramanathan, Ralph H. B. Benedict, Robert Zivadinov & Bianca Weinstock-Guttman. (2019) Epidemiology and treatment of multiple sclerosis in elderly populations. Nature Reviews Neurology 15:6, pages 329-342.
Crossref
Tomas Uher, Manuela Vaneckova, Jan Krasensky, Lukas Sobisek, Michaela Tyblova, Jana Volna, Zdenek Seidl, Niels Bergsland, Michael G Dwyer, Robert Zivadinov, Nicola De Stefano, Maria Pia Sormani, Eva Kubala Havrdova & Dana Horakova. (2017) Pathological cut-offs of global and regional brain volume loss in multiple sclerosis. Multiple Sclerosis Journal 25:4, pages 541-553.
Crossref
Dejan Jakimovski, Bianca Weinstock-Guttman, Sirin Gandhi, Yi Guan, Jesper Hagemeier, Deepa P. Ramasamy, Tom A. Fuchs, Richard W. Browne, Niels Bergsland, Michael G. Dwyer, Murali Ramanathan & Robert Zivadinov. (2019) Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study. Journal of Neurology 266:4, pages 866-875.
Crossref
Robert Zivadinov, Niels Bergsland, Ellen Carl, Deepa Ramasamy, Jesper Hagemeier, Michael Dwyer, Alexis Lizarraga, Channa Kolb, David Hojnacki & Bianca Weinstock-Guttman. (2019) Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study. Journal of Clinical Medicine 8:3, pages 344.
Crossref
R. Zivadinov, D. Horakova, N. Bergsland, J. Hagemeier, D.P. Ramasamy, T. Uher, M. Vaneckova, E. Havrdova & M.G. Dwyer. (2019) A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS. American Journal of Neuroradiology.
Crossref
Yi Guan, Dejan Jakimovski, Murali Ramanathan, Bianca Weinstock-Guttman & Robert Zivadinov. (2019) The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging . Neural Regeneration Research 14:3, pages 373.
Crossref
Rosa Cortese, Sara Collorone, Olga Ciccarelli & Ahmed T. Toosy. (2019) Advances in brain imaging in multiple sclerosis. Therapeutic Advances in Neurological Disorders 12, pages 175628641985972.
Crossref
H.N. Beadnall, C. Wang, W. Van Hecke, A. Ribbens, T. Billiet & M.H. Barnett. (2019) Comparing longitudinal brain atrophy measurement techniques in a real-world multiple sclerosis clinical practice cohort: towards clinical integration?. Therapeutic Advances in Neurological Disorders 12, pages 175628641882346.
Crossref
Robert Zivadinov, Jennie Medin, Nasreen Khan, Jonathan R. Korn, Tanuja Chitnis, Robert T. Naismith, Enrique Alvarez, Michael G. Dwyer, Niels Bergsland, Ellen Carl, Diego Silva & Bianca Weinstock-Guttman. (2019) Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study. Multiple Sclerosis and Related Disorders 27, pages 65-73.
Crossref
Nicole Ziliotto, Robert Zivadinov, Dejan Jakimovski, Marcello Baroni, Veronica Tisato, Paola Secchiero, Niels Bergsland, Deepa P. Ramasamy, Bianca Weinstock-Guttman, Francesco Bernardi, Murali Ramanathan & Giovanna Marchetti. (2019) Plasma levels of soluble NCAM in multiple sclerosis. Journal of the Neurological Sciences 396, pages 36-41.
Crossref
E. Ghione, N. Bergsland, M.G. Dwyer, J. Hagemeier, D. Jakimovski, I. Paunkoski, D.P. Ramasamy, D. Silva, E. Carl, D. Hojnacki, C. Kolb, B. Weinstock-Guttman & R. Zivadinov. (2018) Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine. American Journal of Neuroradiology 39:12, pages 2237-2242.
Crossref
Dejan Jakimovski, Channa Kolb, Murali Ramanathan, Robert Zivadinov & Bianca Weinstock-Guttman. (2018) Interferon β for Multiple Sclerosis. Cold Spring Harbor Perspectives in Medicine 8:11, pages a032003.
Crossref
Nicole Ziliotto, Francesco Bernardi, Dejan Jakimovski, Marcello Baroni, Niels Bergsland, Deepa P. Ramasamy, Bianca Weinstock-Guttman, Paolo Zamboni, Giovanna Marchetti, Robert Zivadinov & Murali Ramanathan. (2018) Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients. Multiple Sclerosis and Related Disorders 25, pages 37-42.
Crossref
Dejan Jakimovski, Bianca Weinstock-Guttman, Jesper Hagemeier, Caila B. Vaughn, Katelyn S. Kavak, Sirin Gandhi, Susan E. Bennett, Tom A. Fuchs, Niels Bergsland, Michael G. Dwyer, Ralph H.B. Benedict & Robert Zivadinov. (2018) Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage. Journal of the Neurological Sciences 393, pages 128-134.
Crossref
R. Magliozzi, R. Reynolds & M. Calabrese. (2018) MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course . Brain Pathology 28:5, pages 735-742.
Crossref
Robert Zivadinov. (2018) Why Is Cognitive Impairment Present in Multiple Sclerosis? Insights from Functional MRI. Radiology 288:2, pages 552-553.
Crossref
Robert Zivadinov, Eleonora Tavazzi, Jesper Hagemeier, Ellen Carl, David Hojnacki, Channa Kolb & Bianca Weinstock-Guttman. (2018) The Effect of Glatiramer Acetate on Retinal Nerve Fiber Layer Thickness in Patients with Relapsing–Remitting Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study. CNS Drugs 32:8, pages 763-770.
Crossref
Robert Zivadinov, Jennie Medin, Nasreen Khan, Jonathan R. Korn, Niels Bergsland, Michael G. Dwyer, Tanuja Chitnis, Robert T. Naismith, Enrique Alvarez, Peter Kinkel, Stanley Cohan, Samuel F. Hunter, Diego Silva & Bianca Weinstock-Guttman. (2018) Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS. Journal of Neuroimaging 28:4, pages 399-405.
Crossref
Tomas Uher, Jan Krasensky, Lukas Sobisek, Zdenek Seidl, Niels Bergsland, Michael G. Dwyer, Eva Kubala Havrdova, Robert Zivadinov, Dana Horakova & Manuela Vaneckova. (2018) The Role of High‐Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis. Journal of Neuroimaging 28:3, pages 328-337.
Crossref
R. Zivadinov, J. Hagemeier, N. Bergsland, E. Tavazzi & B. Weinstock‐Guttman. (2018) Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study. European Journal of Neurology 25:3, pages 584.
Crossref
R. Zivadinov, N. Bergsland, J.R. Korn, M.G. Dwyer, N. Khan, J. Medin, J.C. Price, B. Weinstock-Guttman & D. Silva. (2018) Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS. American Journal of Neuroradiology 39:2, pages 289-295.
Crossref
G. Lu, H.N. Beadnall, J. Barton, T.A. Hardy, C. Wang & M.H. Barnett. (2018) The evolution of “No Evidence of Disease Activity” in multiple sclerosis. Multiple Sclerosis and Related Disorders 20, pages 231-238.
Crossref
Michael G. Dwyer, Jesper Hagemeier, Niels Bergsland, Dana Horakova, Jonathan R. Korn, Nasreen Khan, Tomas Uher, Jennie Medin, Diego Silva, Manuela Vaneckova, Eva Kubala Havrdova & Robert Zivadinov. (2018) Establishing pathological cut-offs for lateral ventricular volume expansion rates. NeuroImage: Clinical 18, pages 494-501.
Crossref
. 2018. The Immune System and Mental Health. The Immune System and Mental Health 555 664 .
Bianca Weinstock-Guttman, Jennie Medin, Nasreen Khan, Jonathan R. Korn, Ellen Lathi, Jason Silversteen, Jonathan Calkwood, Diego Silva & Robert Zivadinov. (2017) Assessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study. CNS Drugs 32:1, pages 75-84.
Crossref
Aaron E. Miller. (2017) Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience. Therapeutic Advances in Neurological Disorders 10:12, pages 381-396.
Crossref
Tomas Uher, Jan Krasensky, Manuela Vaneckova, Lukas Sobisek, Zdenek Seidl, Eva Havrdova, Niels Bergsland, Michael G. Dwyer, Dana Horakova & Robert Zivadinov. (2017) A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study. Journal of Neuroimaging 27:6, pages 620-629.
Crossref
Maria Pia Sormani & Matteo Pardini. (2017) Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials. Neurotherapeutics 14:4, pages 924-933.
Crossref
Gavin Giovannoni, Davorka Tomic, Jeremy R Bright & Eva Havrdová. (2017) “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis. Multiple Sclerosis Journal 23:9, pages 1179-1187.
Crossref
Robert Zivadinov, Nasreen Khan, Jennie Medin, Pia Christoffersen, Jennifer Price, Jonathan R. Korn, Ian Bonzani, Michael G. Dwyer, Niels Bergsland, Ellen Carl, Diego Silva & Bianca Weinstock-Guttman. (2017) An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study. Journal of Neuroimaging 27:3, pages 339-347.
Crossref
Jaume Sastre-Garriga, Deborah Pareto & Àlex Rovira. (2017) Brain Atrophy in Multiple Sclerosis. Neuroimaging Clinics of North America 27:2, pages 289-300.
Crossref
Nicola De Stefano, Diego G. Silva & Michael H. Barnett. (2017) Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis. CNS Drugs 31:4, pages 289-305.
Crossref
Michael G. Dwyer, Diego Silva, Niels Bergsland, Dana Horakova, Deepa Ramasamy, Jaqueline Durfee, Manuela Vaneckova, Eva Havrdova & Robert Zivadinov. (2017) Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis. NeuroImage: Clinical 15, pages 769-779.
Crossref
Robert Zivadinov, Michael G Dwyer & Niels Bergsland. (2016) Brain atrophy measurements should be used to guide therapy monitoring in MS – YES. Multiple Sclerosis Journal 22:12, pages 1522-1524.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.